Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran

被引:0
作者
Hadi Poormoghim
Elham Andalib
Arash Jalali
Afshin Ghaderi
Ali Ghorbannia
Nazanin Mojtabavi
机构
[1] Iran University of Medical Sciences,Scleroderma Study Group, Firoozgar Hospital
[2] Firoozgar Hospital,Scleroderma Study Group
[3] Tehran University of Medical Sciences,Department of Epidemiology and Biostatistics
[4] Iran University of Medical Sciences,Department of Immunology
来源
Rheumatology International | 2016年 / 36卷
关键词
Systemic sclerosis; Survival; Causes of death;
D O I
暂无
中图分类号
学科分类号
摘要
The aims of the study were to determine prognostic factors for survival and causes of death in a cohort of patients with systemic sclerosis (SSc). This was a cohort study of SSc patients in single rheumatologic center from January 1998 to August 2012. They fulfilled the American College of Rheumatology classification criteria for SSc or had calcinosis Raynaud’s phenomenon, esophageal dysmotility, sclerodactyly, telangiectasia or sine sclerosis. Causes of death were classified as SSc related and non-SSc related. Kaplan–Meier and Cox proportional hazard regression models were used in univariate and multivariate analysis to analyse survival in subgroups and determine prognostic factors of survival. The study includes 220 patients (192 female, 28 male). Out of thirty-two (14.5 %) who died, seventeen (53.1 %) deaths were SSc related and in nine (28.1 %) non-SSc-related causes, and in six (18.8 %) of patients causes of death were not defined. Overall survival rate was 92.6 % (95 % CI 87.5–95.7 %) after 5 years and 82.3 % (95 % CI 73.4–88.4 %) after 10 years. Pulmonary involvement was a major SSc-related cause of death, occurred in seven (41.1 %) patients. Cardiovascular events were leading cause of in overall death (11) 34.3 % and 6 in non-SSc-related death. Independent risk factors for mortality were age >50 at diagnosis (HR 5.10) advance pulmonary fibrosis (HR 11.5), tendon friction rub at entry (HR 6.39), arthritis (HR 3.56). In this first Middle Eastern series of SSc registry, pulmonary and cardiac involvements were the leading cause of SSc-related death.
引用
收藏
页码:925 / 934
页数:9
相关论文
共 176 条
[1]  
Medsger TA(1971)Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients Ann Intern Med 75 369-376
[2]  
Masi AT(2010)Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis Rheumatology 49 1112-1117
[3]  
Rodnan GP(2011)Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres Ann Rheum Dis 70 1788-1792
[4]  
Benedek TG(1998)Mortality and causes of death in a Swedish series of systemic sclerosis patients Ann Rheum Dis 57 682-686
[5]  
Robinson H(2012)Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients J Rheumatol 39 10-153
[6]  
Perez-Bocanegra C(2002)Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients Medicine 81 139-148
[7]  
Solans-Laque R(1992)Mortality in systemic sclerosis (scleroderma) Q J Med 82 139-63
[8]  
Simeon-Aznar CP(2008)Survival and causes of death in 366 Hungarian patients with systemic sclerosis Ann Rheum Dis 67 59-302
[9]  
Fransen J(2010)The prognostic factors of systemic sclerosis for survival among Koreans Clin Rheumatol 29 297-75
[10]  
Popa-Diaconu D(2003)Mortality and prognostic factors in Spanish patients with systemic sclerosis Rheumatology 42 71-277